The 20 Best Angiosarcoma Doctors Near Me in Westminster, MD

Katherine Thornton is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Thornton is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Angiosarcoma, Synovial Sarcoma, and Bone Tumor.

Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer. Dr. Wolff is board certified in American Board Of Internal Medicine.

Dr. Rima Jean Couzi is a cancer specialist in Towson, Maryland, caring for patients with breast cancer. Dr. Couzi earned her medical degree at the National University of Ireland. She completed residencies at St. Laurence's Hospital/Beaumont Hospitals and Galway Regional in Dublin, as well as Franklin Square Hospital in Baltimore. She performed a fellowship in medical oncology at St. Vincent's Hospital and St. James's Hospital in Dublin, and an additional fellowship in medical oncology at Johns Hopkins Oncology Center in Baltimore. She also earned a master’s degree in clinical epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Couzi joined the Johns Hopkins faculty in 2004. Dr. Couzi is a member of the American Society of Clinical Oncology and the Royal College of Physicians in Ireland. Selected Publications Antonarakis ES, Fradin JM, Petronis JD, Couzi RJ. “Not What It Seems.” Am J Med. 2007;120:408-411 Holdhoff M, Wung PK, Petronis J, Couzi R. “Persistent PET-positive liver lesions after successful chemotherapy in a patient with mediastinal seminoma.” J. Clin Oncol. 2007;25:2482-4. Li S, Couzi RJ, Thomas GH, Friedman AD, Borowitz MJ. “A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy.” Cancer Genet Cytogenet. 2001; 125:74-7. Schultz MJ, Tabb RD, Eagan JW, Citron JR, Couzi RJ. “Treating a male breast cancer patient with moderately differentiated, infiltrating ductal cancer of the breast.” Journal of Multidisciplinary Cancer Care. 2009 September – October. Siegelbaum MH, Citron JR, Eagan JW, Couzi RJ. “Treating a patient with Unfavorable-risk prostate cancer.” Journal of Multidisciplinary Cancer Care. 2009; July – August. Dr. Couzi is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Couzi is board certified in American Board Of Internal Medicine.

Dr. Jacobs is the Division Chief of the Division of Breast Cancer Surgery. She also established the Johns Hopkins Medicine Breast Center at Johns Hopkins Howard County Medical Centerl in Columbia. Dr. Jacobs sees patients at both The Johns Hopkins Hospital and at Johns Hopkins Howard County Medical Center. As division chief of breast cancer surgery, Dr. Jacobs leads an expert team of 9 surgeons located at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore; Johns Hopkins Howard County Medical Center; Sibley Memorial Hospital in Washington, D.C.; and Suburban Hospital in Bethesda. She has also initiated new clinics at Johns Hopkins Health Care & Surgery Center - Green Spring Station in Lutherville; Johns Hopkins Howard County Medical Center, and the Skip Viragh Outpatient Center Building in Baltimore. Dr. Jacobs is committed to providing excellent, comprehensive, and patient-centered breast cancer care throughout Johns Hopkins Medicine through close collaboration with oncology, plastic surgery, nursing, rehabilitation medicine, and genetic services. Additionally, Dr. Jacobs has a clinical interest in the treatment of early stage melanoma. She works closely with dermatologists and medical oncologists at Johns Hopkins University and Johns Hopkins Howard County Medical Center to improve awareness and care of melanoma patients by participating in educational programs and clinical research trials. She has also launched research programs in lymphedema and oncoplastic surgery to increase the number of women eligible for breast prevention by combining lumpectomy with plastic surgery techniques to reshape the breast. In addition, Dr. Jacobs is the surgery representative to the National Clinical Trials Network for the Johns Hopkins Executive Committee and the institutional surgery representative to the Translational Breast Cancer Research Consortium. She serves as the Chair of the Cancer Committee at The Johns Hopkins Hospital and at Johns Hopkins Howard County Medical Center, which establishes both programmatic and quality improvement goals for cancer care across the health system on a yearly basis. Dr. Jacobs is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Jacobs is board certified in American Board Of Surgery.

Dr. Susan Bahl, MD, FACS, is a distinguished Breast Surgeon who recently joined Johns Hopkins, practicing at both Howard County Medical Center and Johns Hopkins Bayview Medical Center. A strong advocate for women's health, Dr. Bahl brings over a decade of experience in providing state-of-the-art, evidence-based breast care within multidisciplinary settings. She has a passion for delivering personalized treatment plans to patients, specializing in both benign and malignant breast diseases. Before joining Johns Hopkins, Dr. Bahl served as the Medical Director of the Frederick Health Breast Center, where she founded a NAPBC-accredited multidisciplinary breast cancer clinic. In this role, she helped streamline the treatment process for newly diagnosed breast cancer patients by coordinating care between breast surgeons, medical oncologists, and radiation oncologists. Dr. Bahl also co-directed a Breast Screening and Prevention Program designed for high-risk women, integrating genetic testing, risk-reduction surgeries, and chemo-prevention strategies. Her commitment to patient-centered care and leadership in breast health make her a valuable addition to the Johns Hopkins community. Dr. Bahl is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Breast Lump, Angiosarcoma, and Lymphadenectomy. Dr. Bahl is board certified in American Board Of Surgery.

Blanche Mavromatis, MD, specializes in hematology oncology and is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mavromatis completed her fellowship at Georgetown University Hospital, residency at Georgetown University Medical Center and medical degree from Thomas Jefferson University Medical College. Dr. Mavromatis is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 67 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Mavromatis is board certified in American Board Of Internal Medicine. Dr. Mavromatis is currently accepting new patients.

Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Santa is board certified in American Board Of Internal Medicine.

Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care. Dr. Lange is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy. Dr. Lange is board certified in American Board Of Surgery.

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Ganglioneuroblastoma, and Bone Tumor. Dr. Meyer is board certified in American Board Of Internal Medicine.

Dr. Melissa Camp is the lead breast surgeon in the Johns Hopkins Kimmel Cancer Center's Breast Program at Green Spring Station. As the lead breast surgeon, Dr. Camp works closely with experts from medical oncology, radiation oncology, imaging and pathology to deliver comprehensive multidisciplinary breast cancer care to patients in a convenient community setting. Dr. Camp specializes in providing compassionate breast cancer treatment, including nipple-sparing mastectomy and breast conservation surgery, and helping newly-diagnosed patients navigate the decision-making process. She sees patients at The Johns Hopkins Hospital and at Johns Hopkins Health Care & Surgery Center - Green Spring Station. Dr. Camp received her bachelor’s degree in biochemistry/molecular biology summa cum laude from Dartmouth College. She graduated from the Johns Hopkins University School of Medicine and went on to complete residencies in general surgery and preventive medicine and to earn a master's degree in public health from the Johns Hopkins Bloomberg School of Public Health. As a member of the American Society of Breast Surgeons and the Society of Surgical Oncology, Dr. Camp has published several peer-reviewed journal articles and has presented her work at national and international medical meetings. Dr. Camp is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Subareolar Abscess, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy. Dr. Camp is board certified in American Board Of Surgery.

Neil Friedman is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Lymphadenectomy, and Mastectomy.

Jennifer Joh is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Joh is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Lymphadenectomy, and Mastectomy.

Elizabeth Nichols is a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Nichols is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Cervical Cancer, and Neuroendocrine Carcinoma of the Cervix. Dr. Nichols is board certified in American Board Of Radiology.

Holly Dushkin is a Hematologist and a Hematologist Oncology provider practicing medicine in Chevy Chase, Maryland. Dr. Dushkin is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Dr. Dushkin is board certified in American Board Of Internal Medicine.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Garg is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura. Dr. Garg is board certified in American Board Of Internal Medicine.

Roy Chisholm, MD, specializes in general surgery and is board certified in surgery by the American Board of Surgery. He practices at UPMC Western MD Specialty Services - General Surgery. Dr. Chisholm completed his residency at Union Memorial Hospital and medical education at University of Kentucky College of Medicine. Dr. Chisholm is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Hernia, Cholecystitis, Gallbladder Disease, Bladder Reconstruction, and Colostomy. Dr. Chisholm is board certified in American Board Of Surgery. Dr. Chisholm is currently accepting new patients.

Michael Stasko, MD, specializes in general surgery and is board certified in surgery by the American Board of Surgery. Dr. Stasko completed his residency at Baystate Medical Center and medical education at University of Maryland School of Medicine. Dr. Stasko is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Chronic Subdural Hematoma, Paget Disease of the Breast, Anorectal Abscess, Lymphadenectomy, and Colostomy. Dr. Stasko is board certified in American Board Of Surgery. Dr. Stasko is currently accepting new patients.

"Dr. Fariba Asrari is the director of Johns Hopkins Breast Center at Green Spring Station. She received her medical degree with honors from Shiraz Medical School in Iran and completed Internal medicine residency training at affiliated Hospitals of University of Pennsylvania in Philadelphia. She then completed her second residency training in Radiation Oncology at Hahnemann university in Philadelphia. She is an active member of the American Society for Therapeutic Radiology and Oncology as well as the American Medical Association, American Radium Society, Mid-Atlantic Society of Radiation Oncologists and American Society of Clinical Oncology. She is the treasurer of Mid-Atlantic Society of Radiation Oncologists. Dr. Asrari's special interest is in breast and gynecologic malignancies as well as skin cancer. She also participates in resident and medical student teaching. She is the recipient of 2006 Director's Teaching Award in Clinical Science at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and 2006 ""Teacher of The Year Award"" of Association of Residents in Radiation Oncology. She also has received 2005 Thomas Fercoit Memorial Professional of The Year Award from ""The ARC of Baltimore"" in appreciation of her dedicated care of individuals with developmental disabilities. Make A Gift". Dr. Asrari is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Prostate Cancer, Merkel Cell Carcinoma, and Angiosarcoma. Dr. Asrari is board certified in American Board Of Radiology.

Dr. Armstrong works primarily in the area of women's malignancies, with a particular emphasis on breast cancer, ovarian cancer and other gynecologic malignancies, and the genetics of breast and ovarian cancer. She directs the medical gynecologic oncology clinical service and oversees therapeutic clinical trials in gynecologic cancers. Dr. Armstrong's clinical focus is on the development of new therapeutic approaches to the treatment of breast cancer and gynecologic malignancies. Particular areas of interest are intraperitoneal therapy in ovarian cancer and targeted biologic therapies. Dr. Armstrong also directs the Kimmel Cancer Center's Breast and Ovarian Cancer Screening Service, a genetic counseling service that focuses on identifying patients at risk for cancer and examination of new strategies for cancer screening and prevention. Dr. Armstrong has lectured locally, nationally and internationally. She is active in the Gynecologic Oncology Group, serving on the Medical Oncology, Developmental Therapeutics and Phase I GOG committees and as chair of several clinical trials through this group. She is a representative of the Southwest Oncology Group to the Gynecologic Cancer Steering Committee of the National Cancer Institute. Dr. Armstrong also serves as a representative of Johns Hopkins to the National Cooperative Cancer Network serving on the ovarian cancer and breast cancer risk reduction panels. She has participated as a member of the Cancer Working Group for the Office of Research on Women's Health for the National Institutes of Health, as a scientific reviewer for the breast and ovarian cancer research programs of the Department of Defense and the National Cancer Institute, as a reviewer for the NCI Special Emphasis Panel for Insight Awards to Stamp Out Breast Cancer and as a member of the NCI SPORE Program parent committee. Dr. Armstrong also is co-principal investigator for the NCI National Clinical Trials Network (NCTN) Lead Academic Participating Site (LAPS) at Johns Hopkins, now the major avenue for adult oncology clinical trials in the country. Recent work includes immune checkpoint inhibitor therapy in endometrial cancers with microsatellite instability and PARP inhibition in ovarian cancer. Dr. Armstrong is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Breast Cancer, Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, and Tissue Biopsy. Dr. Armstrong is board certified in American Board Of Internal Medicine.

Milton Lum, MD, specializes in general surgery and is board-certified in surgery by the American Board of Surgery. He practices at UPMC Western MD Specialty Services - General Surgery. Dr. Lum completed his residency at University of Pittsburgh School of Medicine and medical education at Dalhousie University. Dr. Lum is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Hernia, Cellulitis, Gallbladder Disease, Gallbladder Removal, and Hernia Surgery. Dr. Lum is board certified in American Board Of Surgery. Dr. Lum is currently accepting new patients.